$60,000 of MARSHFIELD CLINIC HEALTH SYSTEM lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Reimbursement, access, workforce, rural health
Reimbursement, access, GME, rural issues
NIH support, funding, NIOSH
Farm Safety/Occupational Safety, food policy, wellness, nutrition
telehealth, rural access
prevention
ACA, Medicare Advantage, Medicaid Managed Care, Individual markets, commercial markets, transparency"
You can find more data on corporate lobbying on Quiver Quantitative.
MRSH Congressional Stock Trading
Members of Congress have traded $MRSH stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MRSH stock by members of Congress over the last 6 months:
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
MRSH Insider Trading Activity
MRSH insiders have traded $MRSH stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $MRSH stock by insiders over the last 6 months:
- JOHN Q DOYLE (President and CEO) has made 0 purchases and 2 sales selling 33,311 shares for an estimated $5,746,303.
- NICHOLAS MARK STUDER (President and CEO of OWG) sold 3,837 shares for an estimated $706,122
- JOHN JUDE JONES (Chief Marketing Officer) sold 2,362 shares for an estimated $410,067
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
MRSH Hedge Fund Activity
We have seen 648 institutional investors add shares of MRSH stock to their portfolio, and 720 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HARRIS ASSOCIATES L P added 5,169,119 shares (+inf%) to their portfolio in Q1 2026, for an estimated $898,289,499
- FMR LLC removed 5,044,737 shares (-33.1%) from their portfolio in Q1 2026, for an estimated $876,674,395
- CAPITAL RESEARCH GLOBAL INVESTORS added 3,313,394 shares (+41.5%) to their portfolio in Q1 2026, for an estimated $575,801,609
- CAPITAL INTERNATIONAL INVESTORS removed 3,052,962 shares (-16.3%) from their portfolio in Q1 2026, for an estimated $530,543,736
- AQR CAPITAL MANAGEMENT LLC added 2,195,968 shares (+148.6%) to their portfolio in Q1 2026, for an estimated $381,615,319
- AMERICAN CENTURY COMPANIES INC added 1,903,819 shares (+81.7%) to their portfolio in Q1 2026, for an estimated $330,845,665
- GEODE CAPITAL MANAGEMENT, LLC added 1,760,147 shares (+15.1%) to their portfolio in Q1 2026, for an estimated $305,878,345
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
MRSH Analyst Ratings
Wall Street analysts have issued reports on $MRSH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 02/02/2026
To track analyst ratings and price targets for MRSH, check out Quiver Quantitative's $MRSH forecast page.
MRSH Price Targets
Multiple analysts have issued price targets for $MRSH recently. We have seen 13 analysts offer price targets for $MRSH in the last 6 months, with a median target of $200.0.
Here are some recent targets:
- Yaron Kinar from Mizuho set a target price of $197.0 on 07/09/2026
- Ryan Tunis from Cantor Fitzgerald set a target price of $218.0 on 07/09/2026
- Brian Meredith from UBS set a target price of $212.0 on 07/08/2026
- Bob Huang from Morgan Stanley set a target price of $175.0 on 07/06/2026
- Paul Newsome from Piper Sandler set a target price of $182.0 on 05/26/2026
- Matthew Heimermann from Citigroup set a target price of $200.0 on 05/06/2026
- Meyer Shields from Keefe, Bruyette & Woods set a target price of $203.0 on 04/17/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
Read full article here »
View the Zacks #1 Rank List
Lobbying Update: $60,000 of MARSHFIELD CLINIC HEALTH SYSTEM lobbying was just disclosed
$60,000 of MARSHFIELD CLINIC HEALTH SYSTEM lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Reimbursement, access, workforce, rural health Reimbursement, access, GME, rural issues NIH support, funding, NIOSH Farm Safety/Occupational Safety, food policy, wellness, nutrition telehealth, rural access prevention ACA, Medicare Advantage, Medicaid Managed Care, Individual markets, commercial markets, transparency"
You can find more data on corporate lobbying on Quiver Quantitative.
MRSH Congressional Stock Trading
Members of Congress have traded $MRSH stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MRSH stock by members of Congress over the last 6 months:
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
MRSH Insider Trading Activity
MRSH insiders have traded $MRSH stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $MRSH stock by insiders over the last 6 months:
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
MRSH Hedge Fund Activity
We have seen 648 institutional investors add shares of MRSH stock to their portfolio, and 720 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
MRSH Analyst Ratings
Wall Street analysts have issued reports on $MRSH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
To track analyst ratings and price targets for MRSH, check out Quiver Quantitative's $MRSH forecast page.
MRSH Price Targets
Multiple analysts have issued price targets for $MRSH recently. We have seen 13 analysts offer price targets for $MRSH in the last 6 months, with a median target of $200.0.
Here are some recent targets:
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
Read full article here »